CSIMarket


Boston Scientific Corporation  (BSX)
Other Ticker:  
 

Boston Scientific Corporation

BSX's Fundamental analysis








Looking into Boston Scientific growth rates, revenue grew by 10.97 % in II. Quarter 2023 from the same quarter a year ago. Ranking at No. 951

Medical Equipment & Supplies industry recorded growth of revenues by 4.79 %

Boston Scientific's net income grew by 3.85 % in II. Quarter 2023 year on year, above company average,

More on BSX's Growth


Boston Scientific
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 25.91 Company is currently trading with Price to Cash flow multiple of 481.8 in trailing twelve-month period.
Company
89.87
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.09.


More on BSX's Valuation
 
 Total Debt (Millions $) 9,053
 Dividend TTM ($) 0.04 $
 Dividend Yield TTM (%) 0.07 %
 Revenue/Employee (TTM) $ 326,878
 Net Income/Employee (TTM) $ 22,244
 Receivable Turnover (TTM) 6.66
 Tangible Book Value (Per Share $) -0.85

Boston Scientific
current PE on trailing twelve month basis is above Medical Equipment & Supplies industry average.

Boston Scientific PEG ratio is at 25.91 Company is currently trading with Price to Cash flow multiple of 481.8 in trailing twelve-month period.
Company
89.87
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 5.82.
Medical Equipment & Supplies industry's Price to Sales ratio is at 4.09.

Boston Scientific Price to Book Ratio is at 4.22 higher than Indusry Avg. of -316.84, and lower than S&P 500 Avg. of 1171.69

More on BSX's Valuation

  Market Capitalization (Millions $) 78,052
  Shares Outstanding (Millions) 1,456
  Employees 41,000
  Revenues (TTM) (Millions $) 13,402
  Net Income (TTM) (Millions $) 912
  Cash Flow (TTM) (Millions $) 162
  Capital Exp. (TTM) (Millions $) -616
  Total Debt (Millions $) 9,053
  Dividend TTM ($) 0.04 $
  Dividend Yield TTM (%) 0.07 %
  Revenue/Employee (TTM) $ 326,878
  Net Income/Employee(TTM) $ 22,244
  Receivable Turnover Ratio (TTM) 6.66
  Tangible Book Value (Per Share $) -0.85

  Market Capitalization (Millions $) 78,052
  Shares Outstanding (Millions) 1,456
  Employees 41,000
  Revenues (TTM) (Millions $) 13,402
  Net Income (TTM) (Millions $) 912
  Cash Flow (TTM) (Millions $) 162
  Capital Exp. (TTM) (Millions $) -616


    BSX's Profitability Comparisons
Boston Scientific faced margin deterioraten, primarily through cost pressure. Operating Margin fell in II. Quarter 2023 to 14.28 % from 16.29 % in I. Quarter.

Boston Scientific net profit margin of 7.5 % is currently ranking no. 40 in Medical Equipment & Supplies industry, ranking no. 120 in Healthcare sector and number 1618 in S&P 500.


Profitability by Segment



  Ratio
   Capital Ratio (MRQ) 1.29
  Total Debt to Equity (MRQ) 0.49
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.47
  Inventory Turnover Ratio (TTM) 2.06



Boston Scientific faced margin deterioraten, primarily through cost pressure. Operating Margin fell in II. Quarter 2023 to 14.28 % from 16.29 % in I. Quarter.

Boston Scientific net profit margin of 7.5 % is currently ranking no. 40 in Medical Equipment & Supplies industry, ranking no. 120 in Healthcare sector and number 1618 in S&P 500.

More on BSX's Key Ratios





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com